Plain English with Derek Thompson16 Sep 2025

If GLP-1 Drugs Are Good for Everything, Should We All Be on Them?

To read more of Derek's reporting on GLP-1 drugs, you can subscribe to his Substack here. GLP-1 drugs like Ozempic and Zepbound don't just help with Type 2 diabetes and weight loss. They seem to curb alcohol, cocaine, and tobacco use among addicts. In some studies, they prevent strokes, heart attacks, chronic kidney disease, sleep apnea, and Parkinson's disease. They’re associated with a lower risk of several cancers, including pancreatic cancer and multiple myeloma. Arthritic patients on the drugs experienced relief from knee pain that was “on par with opioid drugs.” A small study found that they reduce migraine headaches by 50 percent. And emerging research suggests they might even slow the rate of memory loss among people diagnosed with Alzheimer’s. Is all of this real? And if it’s real, how is one drug doing so many different things? And if it is doing all those things, why shouldn’t we be developing versions of the drug for just about everyone? Today we have two guests: David D’Alessio, chief of endocrinology and metabolism at the Duke University School of Medicine; and Randy Seeley, a professor of surgery, internal medicine, and nutritional sciences at the University of Michigan. We talk about how these drugs work—why they seem to do everything—and how our understanding of them could make them better, more effective, more broadly useful. If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guests: David D’Alessio and Randy Seeley Producer: Devon Baroldi Disclosure: Dr. Seeley has received research support from several pharmaceutical companies, including Eli Lilly, Diasome, and Amgen. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(405)

The Single Smartest Case Against AI Doom

With new breakthroughs in math and biology alongside reports of AI agents escaping and hacking systems, suffice it to say AI has had an interesting few weeks. How worried should we be about it all? D...

25 Sep 1h 1min

The Truth About Mississippi's Education "Miracle"

Education outcomes have been getting worse across much of the world, with reading and math scores falling to historic lows. The U.S. has seen some of the steepest declines in decades. But, why does ...

18 Sep 56min

Why Experts Keep Getting the Economy So Wrong

Expert economists keep making predictions about America’s financial future, and those predictions keep being … wrong. Over the past few years, we’ve heard warnings about a recession, inflation, tariff...

15 Sep 58min

What’s the Point of College?

Trust in American higher education is near a historic low. Tuition has soared, and the payoff for a college degree is now in question as graduates face a weird and challenging job market. Simultaneous...

11 Sep 56min

The New Book That Scares Big Tech

In the late 19th century, a railroad boom fueled by easy money, speculative investment, and new technology helped kick off one of the worst financial crises in American history. Sound kind of familiar...

8 Sep 59min

AI Slop Is Breaking the Internet. Can We Save It?

So many people seem to hate AI, and it’s not just because it might displace millions of jobs, destroy the world, or deepen distrust in big corporations and government. The reason might actually be sim...

1 Sep 56min

Why Everything Is Going to Keep Getting More Expensive

For much of the 21st century, the U.S. economy was built around cheap money. Today, though, interest rates are rising, and borrowing is getting much more expensive. At the same time, the federal gover...

25 Aug 41min

Higher Education’s Age of ‘Insufferable Hypocrisy’

It would be an understatement to say that higher education is in crisis, as it faces attacks from both the current presidential administration as well as issues of its own making, like diversity polit...

18 Aug 1h 2min